Safety and Efficacy of Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation

被引：0
|
作者：
Waghray, Abhijeet [1 ]
Balci, Bengi [1 ]
El-Gazzaz, Galal [1 ]
Miller, Charles M. [1 ]
Pelley, Robert J. [1 ]
Aucejo, Federico N. [1 ]
Menon, K. V. Narayanan [2 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
559
引用
收藏
页码：463A / 464A
页数：2
相关论文
共 50 条
  • [21] Sorafenib treatment in recurrent hepatocellular carcinoma post liver transplantation.
    Fallah-Rad, Nazanin
    Cao, Yanshuo
    Sapisochin, Gonzalo
    Dhani, Neesha C.
    Knox, Jennifer J.
    Grant, David
    Jang, Raymond Woo-Jun
    Greig, Paul David
    Lilly, Leslie
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    De Simone, P.
    Crocetti, L.
    Pezzati, D.
    Bargellini, I.
    Ghinolfi, D.
    Carrai, P.
    Leonardi, G.
    Della Pina, C.
    Cioni, D.
    Pollina, L.
    Campani, D.
    Bartolozzi, C.
    Lencioni, R.
    Filipponi, F.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (01) : 241 - 244
  • [23] Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
    Jan Pfeiffenberger
    Ronald Koschny
    Katrin Hoffmann
    Arianeb Mehrabi
    Anne Schmitz
    Boris Radeleff
    Wolfgang Stremmel
    Peter Schemmer
    Tom M. Ganten
    Langenbeck's Archives of Surgery, 2013, 398 : 1123 - 1128
  • [24] Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
    Pfeiffenberger, Jan
    Koschny, Ronald
    Hoffmann, Katrin
    Mehrabi, Arianeb
    Schmitz, Anne
    Radeleff, Boris
    Stremmel, Wolfgang
    Schemmer, Peter
    Ganten, Tom M.
    LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (08) : 1123 - 1128
  • [25] TOLERABILITY AND EFFICACY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY
    Dharancy, Sebastien
    Romano, Olivier
    Lorho, Richard
    Pageaux, Georges Philippe
    de Ledinghen, Victor
    Hurtova, Monika
    Vanlemmens, Claire
    Salame, Ephrem
    Wolf, Philippe
    Dumortier, Jerome
    Hilleret, Marie Noelle
    Cattan, Stephane
    Mathurin, Philippe
    Pruvot, Francois Rene
    HEPATOLOGY, 2008, 48 (04) : 310A - 310A
  • [26] Treatment of recurrent hepatocellular carcinoma after liver transplantation
    Kim, Hye Ryun
    Cheon, Seong Ha
    Rha, Sun Young
    Lee, Soohyeon
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Lee, Jong Doo
    Sung, Jin Sil
    Chung, Hyun Cheol
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (03) : 258 - 269
  • [27] Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Davis, Eric
    Wiesner, Russell
    Valdecasas, Juan
    Kita, Yoshiaki
    Rossi, Massimo
    Schwartz, Myron
    LIVER TRANSPLANTATION, 2011, 17 : S162 - S166
  • [28] An updated retrospective review of the safety and efficacy of sorafenib for recurrent hepatocellular carcinoma post-liver transplantation.
    Feng, Sophie
    Fallah-Rad, Nazanin
    Cao, Yanshuo
    Knox, Jennifer J.
    Jang, Raymond Woo-Jun
    Dhani, Neesha C.
    Sapisochin, Gonzalo
    Grant, David
    Greig, Paul D.
    Lilly, Leslie
    Gorgen, Andre
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [29] Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation?
    Cho, Eun Ju
    Kang, Seong Hee
    Cho, Hyeki
    Cho, Young Youn
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2016, 64 : 658A - 658A
  • [30] Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
    Almhanna, Khaldoun
    Philip, Philip A.
    ONCOTARGETS AND THERAPY, 2009, 2 : 261 - 267
12345